Omega-3 effects on Patient with attention deficit hyperactivity disorder

Comparison of therapeutic effects of Omega-3 and methylphenidate(Ritalin) in treating patients with Attention Deficit Hyperactivity Disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201304035393N3

Enrollment

Registered

2013-07-03

Start date

2009-06-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity disorder. Disturbance of activity and attention

Interventions

(Control: Methylphenidate(Ritalin), 0.3-1 mg/kg three times a day ) (Intervention: Therapeutic doses of Omega-3 (1 gr), 3 capsules divided in three days with Methylphenidate(Ritalin), 0.3-1 mg/kg thre

Treatment - Drugs

(Control: Methylphenidate(Ritalin), 0.3-1 mg/kg three times a day ) (Intervention: Therapeutic doses of Omega-3 (1 gr), 3 capsules divided in three days with Methylphenidate(Ritalin), 0.3-1 mg/kg thr

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: (Inclusion criteria: Children with Score > 65 on both parents and teachers version of Conners rating scale; IQ > 70 using Kaufman brief intelligence test; Informed consent) (Exclusion Criteria:occurrence of unintended side effects;previous treatment of ADHD; omega 3 supplement consumption during past 3 months;severe psychiatric disorders )

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Connors standard test for ADHD patients. Timepoint: 4 weeks. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Reza Soltani

Yazd Branch, Islamic Azad university

hrsgmed@yahoo.com+98 35 1821 0540

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026